Objective: A simple, selective, sensitive, specific, and spectrophotometric method has been developed for the detection of imatinib mesylate in pure form and formulations.
INTRODUCTION
Imatinib mesylate is a prescribed cancer drug for the treatment of leukemia and gastrointestinal tumors. It works by inhibiting cancer cell growth-related proteins to relieve symptoms, prevent cancer cells from spreading, and help other treatments. Imatinib mesylate is one of the newest anticancer drugs on the market and was one of the first drugs to be pushed through the Food and Drug Administration quick track approval designation. The drug is designed to be inhibitors of Bcr-Abl tyrosine kinase inhibitors and is used to treat chronic myeloid leukemia and gastrointestinal stromal tumors.
Imatinib mesylate's chemical name is 4-4[(4-methyl-1-piperazinyl) methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]phenyl]benzamide mono methanesulfonate. It has C 29 H 31 N 7 O.CH 4 O 3 S molecular formula and a 589.71 molecular weight. It has the structural formula which is presented in Fig. 1 . Imatinib mesylate is a white crystalline powder distilled water, 0.1 N HCl, methanol, and dimethyl ether sparingly soluble [1] . Review of literature reveals that only a few methods such as ultraviolet (UV) [2] [3] [4] [5] [6] [7] , colorimetery [8, 9] , biological fluid using high-performance liquid chromatography (HPLC) [10] , reversed phase-HPLC [3, [11] [12] [13] , LC [14] [15] [16] , LC-mass spectrometry [17] and ultrafast LC [18] were developed for the determination of imatinib mesylate in pure and pharmaceutical preparation.
MATERIALS

Instruments
Absorption spectral measurements were carried out with a Systronics 2202 UV-visible spectrophotometry and for sonication Branson 2510 Sonicator was used.
Chemicals
Imatinib mesylate obtained as a gift sample from Aspen Biopharma, Hyderabad, Telangana. Imatinib mesylate tablet formulations (100 mg) were procured from local pharmacies. Hydrochloric acid was of AR grade from Nice Pharmaceuticals Pvt. Ltd., and in house produced distilled water was used.
METHODS
Preparation of stock solution
About 100 mg of mg imatinib mesylate drug in pure form was weighed quantitatively and transferred to a 100 ml standard measuring flask, 0.1 M HCl was added to the above flask, dissolved, and sonicated for 15 min, and the capacity was made up to100 ml with 0.1 M HCl to obtain a final concentration of 1 mg/ml.
Determination of absorbance maxima
An appropriate aliquot portion of 2 ml of imatinib mesylate from a stock solution of imatinib mesylate was moved to 100 ml standard measuring flask, mixed with 0.1 N HCl and the volume was made up to 100 ml with 0.1 N HCl to obtain the concentration 20 µg/ml of imatinib mesylate. Drug solutions were scanned in spectrophotometry and the absorbance maxima were determined.
Validation of the proposed method
The anticipated method was authenticated as per the International Council for Harmonisation Q2 (R1) guidelines for linearity, range, accuracy, precision, stability, limit of detection (LOD), and limit of quantification (LOQ) [19] .
Linearity and range
An appropriate aliquot portion of 0.5, 1, 1.5, 2, 2.5, 3, 3.5, and 4 ml of imatinib mesylate from standard solution was transferred to 100 ml standard measuring flasks and dissolved in 0.1 M HCl volumes were made up to 100 ml with same solvents to obtain 0.5, 1, 1.5, 2, 2.5, 3, 3.5, and 4 µg/ml concentrations of imatinib mesylate. The absorbance of all the subsequent solutions was measured at 232.0 nm. The calibration curve was constructed by plotting drug concentration versus absorbance.
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Precision Ten tablets were weighed accurately and crushed into a fine powder. An accurately weighed quantity of powder equivalent to 100 mg of imatinib mesylate was transferred to 100 ml volumetric flask. About 25 ml of 0.1 M HCl was added and sonicated for 5 min, made up the volume with 0.1 M HCl and filtered. The resulting filtrate was measured at 232.0 nm using spectrophotometry.
Accuracy
A working standard solution of imatinib mesylate was prepared with 0.1 M HCl in a concentration of 2 mg/ml. Equivalent to 50 mg of imatinib mesylate (about 99 mg of tablet powder) weighed accurately and moved into three different 100 ml standard measuring flasks. About 25 ml of 0.1 N HCl was added and 12.5 ml (50%), 25 ml (100%), and 37.5 ml (150%) of the standard solution were added which contains 2 mg/ml of imatinib mesylate. The solution was sonicated for 5 min, made up the volume up to 100 ml with 0.1 N HCl. The resulting solutions were filtered separately and the filtrate of the solution was used to measure the absorbance at 232.0 nm using 0.1 N HCl as solvent blank. It was repeated for three times of different weighing at each level so that nine different weighings were performed.
LOD
The detection limit of a distinct analytical practice is the lowest amount of substance in a mixture which can be detected but not essentially quantitated as an exact value.
Limit of quantitation
The quantitation limit of a distinct analytical practice is the lowest analyte in a sample which can be quantitatively quantified with suitable precision and accuracy.
Ruggedness
Ruggedness is a degree of reproducibility of test outcomes under normal, predictable operational situations from laboratory to laboratory and from analyst to analyst. Ruggedness is determined by the analysis of aliquots by a different analyst. About 2 µg/ml solutions were prepared and analyzed using a spectrophotometer.
Robustness
The robustness of an analytical practice is a measure of capacity to remain unaffected by small, but deliberate variations in method parameters and provides an indication of its reliability during normal usage. It was carried out by changing the wavelength by spectrophotometry with 1 nm difference in wavelength at 231 nmm and 233 nm, respectively.
Stability study
Stability study is an integral part of much analytical procedure. The tests are based on the concept that the equipment, electronics, analytical operation, and samples to be analyzed constitute an integral system that can be evaluated as such. Stability test parameter is to be established for a particular procedure depends on the type of procedure being validated. It was carried out by 2 µg/ml solution which was prepared and measured for 2 h with the interval of 30 min at 232.0 nm using spectrophotometer.
RESULTS AND DISCUSSION
Determination of absorption maximum
Imatinib mesylate is a UV absorbing fragment with definite chromophores in the structure that absorbs at a specific wavelength and this fact was effectively used for their quantitative determinations using the UV spectroscopic method. An absorbance maximum was determined in spectrophotometry by taking 2 µg/ml imatinib mesylate drug which is dissolved in 0.1 N HCl and scanned from 200 to 400 nm using UV-visible spectrophotometer. The absorption spectra presented in Fig. 2 . The spectral analysis showed that the λ max of imatinib mesylate was found to be at 232.0 nm in 0.1 N HCl.
Validation of the proposed method
Linearity and range
Calibration standards for imatinib mesylate covering a range of 0.5-4 µg/ml were prepared in serial dilutions that were made with The absorbance of all resulting concentrations was measured at 232 nm. The graph between the concentration and absorbance was plotted. The regression equation was found to be y = 0.08x. The correlation coefficient (R 2 ) of the standard curve was found to be 0.993. The obtained data are presented in Table 1 . It was found to be linear and hence suitable for the estimation of the drug.
Precision
The results of the precision data were presented in Table 2 for spectrophotometry. The values obtained in the repeatability (precision) shows that there is no significant difference in the precision value. Hence, the developed method can be used to analyze the imatinib mesylate in the tablet formulation. There is no evidence of interference of excipients with imatinib mesylate drug.
The mean precision value was found to be 99.046±0.53%. The value was obtained from 98.22% to 99.4% by spectrophotometric method.
Accuracy
From the data, drug -excipients interactions and/or drug -solvent interactions have not been observed. Since the standard deviation is less than 2% and the mean was above 100%, it was confirmed that there is no interference of any component as excipient is observed by this method. The three level accuracy data is presented in Table 3 .
The percentage of recovery was found to be 100.13±1.37%. The value was obtained from 98.6% to 102.85% by spectrophotometric method.
LOD and LOQ
The LOD was found to be 0.331 µg/ml and the LOQ concentration was found to be 1.004 µg/ml.
Ruggedness
Ruggedness data are presented in Table 4 by the spectrophotometric method, which do not show any significant difference in the absorbance. Hence, the developed method is rugged.
Robustness
There is no significant difference in absorbance observed when the minor changes like the one nanometer difference in spectrophotometric estimation. The observed data were presented in Table 5 .
Stability study
The data show ( Table 6 ) that until the end of 1.5 h, there is no significant difference observed. At the same time after the time within 2 h, the absorbance was drastically reduced. Hence, it was inferred that the sample solution may be stable up to 1.5 h from the preparation of the sample solution.
Validation profile
Performing replicate analysis of the standard solutions was used to assess the accuracy and precision and reproducibility of the proposed methods. The selected concentration for the drug imatinib mesylate within the calibration range was prepared in 0.1 N HCl and analyzed with the relevant calibration curves to determine the intra-day and inter-day variability. The intra-day and inter-day precision were determined and presented in Table 7 .
Estimation of imatinib mesylate by the developed method ensures the selective method than the other methods. The other methods require costly instrument which incurs the cost of analysis and the UV method which has also published do have other solvents. Stability of the solution
